Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and the United States of America (USA). The aim of the
trial is to test if Insulin Detemir as add-on to current Oral Antidiabetic Drug treatment is
at least as effective as Insulin Glargine as add-on to current Oral Antidiabetic Drug
treatment in reducing HbA1c in patients with Type 2 Diabetes.